Zuranolone - Page 1 | CARLAT PUBLISHING

Research Update

Proposed Treatment Algorithm for Postpartum Psychosis

March 1, 2025

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Zuranolone (Zurzuvae) may be FDA-approved for postpartum depression, but we need a very different medication approach for the 1-2 in 1,000 who develop postpartum psychosis.

Clinical Update

Six Recent Disappointments in Psychiatric Research

February 1, 2024

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

Find out where standard therapies like cariprazine and esketamine have failed in recent trials, along with novel medications like minocycline, zuranolone, pimavanserin, and NAC.

Clinical Update

Zuranolone for Postpartum Depression

January 1, 2024

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Assistant Professor, NYU Langone Department of Psychiatry. Practicing psychiatrist, Winston-Salem, NC.

Dr. Aiken has no financial relationships with companies related to this material.

This neurohormone brings fast relief for postpartum depression, but whether it works in regular depression and how long its benefits last is another question.

Clinical Update

Diagnosing and Treating Postpartum Depression

October 3, 2023

Amanda Koire, MD, PhD

Amanda Koire, MD, PhD. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. Dr. Koire has no financial relationships with companies related to this material.

Postpartum depression is surprisingly common, yet often missed. We discuss screening techniques to ensure you won’t miss it, and share treatment approaches, including novel strategies like brexanolone, zuranolone, and TMS.

Expert Q&A

Management of Depression During Pregnancy and Breastfeeding

October 3, 2023

Karen Horst, MD

Karen Horst, MD.

Assistant Professor, Department of OB/GYN, Baylor College of Medicine; Medical Director, The Women’s Place, Pavilion for Women at Texas Children’s Hospital, Houston, TX.

Dr. Horst has no financial relationships with companies related to this material.

You might worry about prescribing antidepressants during pregnancy, but data on their safety is increasingly reassuring. We provide an in-depth review on how to treat depression in pregnancy and breastfeeding.

Zuranolone: 10 Questions about a New Antidepressant

August 14, 2023

Chris Aiken, MD

Zuranolone (Zurzuvae) is newly approved for postpartum depression, but does it work in regular depression? And why did they put so many “Zs” in the name?